詳細検索

詳細検索

詳細検索

お問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/06/12 10:26

161.18 円

186.80 円

218.82 円

医療 市場調査レポート

このリストでは医療市場に関する調査レポートを新刊順に紹介しています。
例えば、医療IT、 医療/ヘルスケア、プライマリケア、医療機器といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。

OpenEvidence, Inc. - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
OpenEvidence, Inc. - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary OpenEvidence, Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of OpenEv…
このレポートの詳細ページはこちら
Komodo Health, Inc. - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Komodo Health, Inc. - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Komodo Health, Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Komod…
このレポートの詳細ページはこちら
Radius Health Inc. (RDUS:NASD) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Radius Health Inc. (RDUS:NASD) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Radius Health Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Radius…
このレポートの詳細ページはこちら
Magellan Health, Inc. (MGLN:NASD) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Magellan Health, Inc. (MGLN:NASD) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Magellan Health, Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Mag…
このレポートの詳細ページはこちら
Karo Healthcare AB (KARO:STO) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Karo Healthcare AB (KARO:STO) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Karo Healthcare AB Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Karo H…
このレポートの詳細ページはこちら
Synairgen Limited (SNG:LSE) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Synairgen Limited (SNG:LSE) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Synairgen Limited Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Synairg…
このレポートの詳細ページはこちら
Revance Therapeutics Inc. - Strategic SWOT and PESTLE Analysis  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Revance Therapeutics Inc. - Strategic SWOT and PESTLE Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 225 |  Quaintel Research | 2026年6月
Report Summary Revance Therapeutics Inc. Strategic SWOT, PESTLE Analysis Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Operational KPI’s and Recent Trends Report is a comprehensive…
このレポートの詳細ページはこちら
PerkinElmer U.S. LLC - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
PerkinElmer U.S. LLC - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary PerkinElmer U.S. LLC Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Perk…
このレポートの詳細ページはこちら
Genetix Biotherapeutics Inc - Strategic SWOT and PESTLE Analysis  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Genetix Biotherapeutics Inc - Strategic SWOT and PESTLE Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 225 |  Quaintel Research | 2026年6月
Report Summary Genetix Biotherapeutics Inc Strategic SWOT, PESTLE Analysis Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Operational KPI’s and Recent Trends Report is a comprehensi…
このレポートの詳細ページはこちら
Blackmores Ltd (BKL:ASX) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Blackmores Ltd (BKL:ASX) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Blackmores Ltd Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Blackmores…
このレポートの詳細ページはこちら
Amedisys Inc. - Strategic SWOT and PESTLE Analysis  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Amedisys Inc. - Strategic SWOT and PESTLE Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 225 |  Quaintel Research | 2026年6月
Report Summary Amedisys Inc. Strategic SWOT, PESTLE Analysis Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Operational KPI’s and Recent Trends Report is a comprehensive and easily …
このレポートの詳細ページはこちら
Meridian Bioscience Inc. (VIVO:NASD) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Meridian Bioscience Inc. (VIVO:NASD) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Meridian Bioscience Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of …
このレポートの詳細ページはこちら
Hanger Inc. (HNGR:NYS) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Hanger Inc. (HNGR:NYS) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Hanger Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Hanger Inc. '…
このレポートの詳細ページはこちら
Healthway Medical Corp Ltd (5NG:SES) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Healthway Medical Corp Ltd (5NG:SES) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Healthway Medical Corp Ltd Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview o…
このレポートの詳細ページはこちら
Fresenius SE & CoKGaA (FRE:GER) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Fresenius SE & CoKGaA (FRE:GER) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Fresenius SE & CoKGaA Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Fre…
このレポートの詳細ページはこちら
Elos Medtech AB (ELOS B:STO) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Elos Medtech AB (ELOS B:STO) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Elos Medtech AB Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Elos Medt…
このレポートの詳細ページはこちら
Biosynex SA(Chembio Diagnostic Inc.) - Strategic SWOT Insights  - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
Biosynex SA(Chembio Diagnostic Inc.) - Strategic SWOT Insights - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends
価格 US$ 195 |  Quaintel Research | 2026年6月
Report Summary Biosynex SA(Chembio Diagnostic Inc.) Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible …
このレポートの詳細ページはこちら
世界の医療用カルボマーゲル市場の成長(2026年~2032年)
世界の医療用カルボマーゲル市場の成長(2026年~2032年)
Global Medical Carbomer Gel Market Growth 2026-2032
価格 US$ 3,660 |  LP Information | 2026年6月
世界の医療用カルボマーゲル市場規模は、2025年のXX百万米ドルから2032年にはXX百万米ドルへと拡大すると予測されており、2026年から2032年にかけて年平均成長率(CAGR)XX%で成長すると見込まれています。 医療用カルボマーゲルは、高分子量ポリマーであるカルボマーを原料…
このレポートの詳細ページはこちら
細胞培養市場成長のグローバルな要因(現状と展望)2026-2032年
細胞培養市場成長のグローバルな要因(現状と展望)2026-2032年
Global Growth Factors for Cell Culture Market Growth (Status and Outlook) 2026-2032
価格 US$ 3,660 |  LP Information | 2026年6月
世界の細胞培養用成長因子市場規模は、2025年の2億6,900万米ドルから2032年には5億3,500万米ドルへと拡大すると予測されており、2026年から2032年にかけて年平均成長率(CAGR)10.5%で成長すると見込まれています。 細胞培養用成長因子は、in vitro(試験管内)において細胞…
このレポートの詳細ページはこちら
世界のiPS細胞治療市場における成長(現状と展望)2026-2032年
世界のiPS細胞治療市場における成長(現状と展望)2026-2032年
Global iPSC Cell Therapies Market Growth (Status and Outlook) 2026-2032
価格 US$ 3,660 |  LP Information | 2026年6月
世界のiPS細胞治療市場規模は、2025年の101億8000万米ドルから2032年には219億7000万米ドルへと拡大すると予測されており、 2026年から2032年にかけて年平均成長率(CAGR)11.8%で成長すると見込まれています。 iPS細胞(人工多能性幹細胞)を用いた細胞治療は、体細胞を遺伝…
このレポートの詳細ページはこちら
カテゴリ別にレポートを見る

ページTOPに戻る